- Dual raltegravir/etravirine combination in virologically suppressed HIV-1-infected patients on antiretroviral therapyRuxandra, Calin; Luc, Paris; Anne, Simon; Gilles, Peytavin; Marc, Wirden; Luminita, Schneider; Marc-Antoine, Valantin; Roland, Tubiana; Rachid, Agher; Christine, KatlamaAntiviral Therapy, 2012, 17(8): 1601-1604.被引 13
- Effects of different treatment regimens on T cell function in acute HIV infectionClutton Genevieve Tyndale; Xu Yinyan; Fernandez Maria Abad; Crooks Amanda; Turner Blair; Maponga Nicole; Cope Anna; Fiscus Susan; McGee Kara; McKellar Mehri; Kuruc JoAnn; Ferrari Guido; Margolis David; Hicks Charles; Eron Joseph; Gay Cindy; Goonetilleke NiluAnnual Meeting of the American-Association-of-Immunologists (AAI), 2016-05-13 To 2016-05-17.
- Long-Term Effectiveness of First-Line Antiretroviral Theraphy in a Cohort of HIV-1 Infected PatientsJordi Navarro-, Mercadé; Manuel, Crespo; Vicenç, Falcó; Eva Van, Den EyndeJournal of Antivirals and Antiretrovirals, 2012, 04(02).
期刊论文
A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses
11阅读
